Implantica wins FDA approval for RefluxStop GERD implant in US

Reuters2026/08/21 03:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

FDA granted Premarket Approval for Implantica’s RefluxStop implant for GERD, clearing the product for U.S. commercialization.
Approval was backed by FDA review of long-term clinical data supporting 5-year safety and effectiveness.
U.S. rollout set to start at selected specialist centers, with uptake expected to build as surgeons are trained.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Implantica AG published the original content used to generate this news brief via PR Newswire (Ref. ID: HS31036) on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Implantica wins FDA approval for RefluxStop GERD implant in US

You may also like

Crypto prices